Extended-spectrum β-lactamase Klebsiella pneumoniae meningitis treated with tigecycline

Annals of Saudi Medicine

Volumn 29, Issue 3, 2009, Pages 240-241

  Wadi, Jamal Ahmad ^a   Selawi, Fadi ^b  

^a JORDAN HOSPITAL   (Jordan)

^b Specialty Hospital Amman   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; TIGECYCLINE;

ADULT; ANTIBIOTIC SENSITIVITY; CASE REPORT; CEREBROSPINAL FLUID CULTURE; COLON INJURY; DEBRIDEMENT; DRUG WITHDRAWAL; DYSPNEA; ENTEROCOCCUS FAECALIS; FATALITY; FEVER; GUNSHOT INJURY; HUMAN; INTESTINE ANASTOMOSIS; INTESTINE RESECTION; KLEBSIELLA PNEUMONIAE INFECTION; LAPAROTOMY; LETTER; LIQUORRHEA; LOADING DRUG DOSE; LUMBAR SPINE; LUNG EMBOLISM; MALE; MENINGITIS; MENINX; PARAPLEGIA; PRIORITY JOURNAL; SEIZURE; SENSORY DYSFUNCTION; SEPSIS; THORAX PAIN; TREATMENT RESPONSE; VERTEBRAL CANAL;

EID: 70350638958     PISSN: 02564947     EISSN: 13199226     Source Type: Journal    
DOI: 10.5144/0256-4947.51776     Document Type: Letter

References (6)

1. Reuben Ramphal and Paul G. Ambrose. Extended-spectrum β-lactamases and clinical outcomes: current data. Clinical Infectious Diseases 2006; 42: S164-72.
2. Gerardo Martínez-Aguilar et al. Outbreak of nosocomial sepsis and pneumonia in a newborn intensive care unit by multiresistant extended spectrum lactamase producing Klebsiella pneumoniae: High Impact on Mortality. Infection Control and Hospital Epidemiology. November 2001; 725-728.
3. Jamal Ahmad Wadi and Mohammad Abu Al Rub. Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline: case report. Ann Saudi Med. November-December 2007; 27(6).
4. Gary A. Noskin. Tigecycline: A new glycylcycline for treatment of serious infections. Clinical Infectious Diseases 2005; 41:S303-14.
5. Timothy Babinchak et al. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: Analysis of Pooled Clinical Trial Data. Clinical Infectious Diseases 2005; 41: S354-67.
6. E. J. Ellis-Grosse. The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam. Clinical Infectious Diseases 2005; 41:S341-53.